bpc 157 gastroparesis BPC-157 Delayed Pro BPC-157 for Gastroparesis Research —

Informed Consent and Patient Education Informed consent discussions for BPC-157 use should clearly communicate the investigational nature of the peptide, lack of FDA approval, limited human safety and efficacy data, and the reliance on animal studies for much of the supporting evidence

European Journal of Pharmacology, 616(13), 147154

AOD 9604 With Retatrutide: Evidence, Safety, and UK Regulatory Status AOD 9604 with retatrutide is a combination increasingly discussed in weight-loss and body-composition circles, yet neither compound holds a Marketing Authorisation from the MHRA or EMA for use in the UK

Blood pressure decreases by an average of 5-10 mmHg systolic

Endometriosis tissue collected from three baboons without drug injection were used as control